Skip to main content
JUDGES SCIENTIFIC PLC logo

JUDGES SCIENTIFIC PLC — Investor Relations & Filings

Ticker · JDG ISIN · GB0032398678 LEI · 2138004EXWWPTW1JOL31 IL Manufacturing
Open in API
Filings indexed 617 across all filing types
Latest filing 2023-08-09 Director's Dealing
Country GB United Kingdom
Listing IL JDG

About JUDGES SCIENTIFIC PLC

https://www.judges.uk.com/

Judges Scientific PLC is a group focused on acquiring and developing a portfolio of scientific instrument businesses. The group's strategy combines corporate expansion through the acquisition of established, niche companies with fostering organic growth within its subsidiaries. These subsidiaries design and produce a wide range of specialized scientific instruments that are sold worldwide. The portfolio serves diverse markets, including higher education institutions, scientific research communities, manufacturers, and regulatory authorities. Key application areas for its instruments include materials science, life sciences (such as electrophysiology and microscopy), geosciences (geological core, soil, and rock analysis), fiber optics, and fire testing technology.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is clearly identified as an RNS (Regulatory News Service) announcement, indicated by the 'RNS Number' and the concluding statement mentioning RNS and the London Stock Exchange. The content details share transactions by persons discharging managerial responsibilities (PDMRs) and directors, specifically noting 'Director/PDMR Shareholding' and reporting purchases of ordinary shares. This type of insider transaction reporting aligns directly with the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific subject matter dictates the DIRS classification over the general RNS fallback.
2023-08-09 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange.' The content announces an increase in the total issued share capital and confirms the total number of voting rights (6,614,189 Ordinary Shares). This type of announcement, which updates the market on share structure relevant for disclosure rules, is a standard regulatory notification. Since it is a general regulatory announcement distributed via RNS and doesn't fit the specific definitions for capital changes (SHA) or director dealings (DIRS), the most appropriate classification is the general regulatory filing category, RNS.
2023-08-02 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is identified by the header 'RNS Number : 2841H' and contains information about share transactions by a Director/PDMR (Chief Financial Officer and Non-Executive Director). This specific type of filing, detailing insider share dealings, corresponds directly to the 'Director's Dealing' category. The presence of the RNS distribution boilerplate confirms it is a regulatory announcement, but the specific content points to DIRS over the general RNS fallback. It is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2023-07-26 English
Half Year Trading Update and Notice of Results
Earnings Release Classification · 92% confidence The document is titled 'Half Year Trading Update and Notice of Interim Results' and provides key trading performance metrics (Order intake, Revenue, Order book) for the six-month period ended 30 June 2023. This content strongly suggests an update on interim financial performance, which aligns with the definition of an Interim/Quarterly Report (IR). However, the document explicitly states: 'The Company intends to announce its interim results for the six months to 30 June 2023 on Wednesday 20 September 2023.' Since this document is an *update* leading up to the formal results announcement, and it is distributed via RNS (indicated by the RNS Number and footer), it functions primarily as a regulatory announcement regarding the period's performance, rather than the comprehensive Interim Report itself (which would likely be filed later as an IR or 10-Q equivalent). Given the nature of the content (trading update) and the explicit notice that the formal results are forthcoming, it is best classified as an Earnings Release (ER) if it were quarterly, but since it is a half-year update and is distributed via the RNS system, the most appropriate classification is a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if we interpret 'Trading Update' as the preliminary earnings announcement. Since it details performance metrics for a defined period (H1), ER is a strong candidate, but the presence of the RNS header and the explicit 'Notice of Results' suggests it's a regulatory disclosure preceding the full report. Given the options, and that it is a pre-results trading update, it is closest to an Earnings Release (ER) which covers key highlights, or RNS as a catch-all. Because it details specific financial performance metrics for the half-year, ER is more specific than RNS. However, the document structure is typical of a regulatory news service announcement (RNS). Let's re-evaluate: It is a trading update for the half-year, not the full interim report. It is a regulatory announcement (RNS Number present). If it were the full report, it would be IR. Since it's a pre-results update, it functions like an ER. Given the context of RNS distribution, RNS is the safest classification for a pre-results trading update announcement, but ER captures the financial nature better. I will lean towards ER as it provides the core financial highlights before the formal results. H1 2023
2023-07-18 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is explicitly labeled as an 'RNS Number' filing and contains multiple sections detailing 'Director/PDMR Shareholding' for various executives (David Cicurel, Bradley Ormsby, Mark Lavelle, Tim Prestidge). This type of filing, reporting personal share transactions by company directors and executives, directly corresponds to the definition of Director's Dealing. Although it is distributed via RNS, the specific content dictates the classification should be DIRS, not the general RNS fallback.
2023-07-10 English
Total Voting Rights
Share Issue/Capital Change Classification · 99% confidence The document begins with an 'RNS Number' and is dated '03 July 2023'. The content explicitly states a confirmation regarding the 'total issued share capital' and the 'total number of voting rights' (6,607,738 Ordinary Shares). This type of announcement, which updates the market on the total number of shares for denominator calculations under disclosure rules, is a standard regulatory disclosure. Since it is a general regulatory announcement that doesn't fit perfectly into specific categories like DIV, SHA, or POS, and it is clearly distributed via RNS (Regulatory News Service), the most appropriate classification is the general regulatory filing category, RNS. It is not a full report (like 10-K or IR) nor a specific transaction report (like DIRS or POS).
2023-07-03 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.